Effects of camel milk in dyslipidaemia: A randomised clinical trial

Adams, 2015, Atorvastatin for lowering lipids, Cochrane Database of Systematic Reviews, 3 Agrawal, 2007, Zero prevalence of diabetes in camel milk consuming Raica community of north-west Rajasthan, India, Diabetes Research and Clinical Practice, 76, 290, 10.1016/j.diabres.2006.09.036 Al Haj, 2010, Compositional, technological and nutritional aspects of dromedary camel milk, International Dairy Journal, 20, 811, 10.1016/j.idairyj.2010.04.003 Al Rasadi, 2016, Dyslipidaemia in the Middle East: Current status and a call for action, Atherosclerosis, 252, 182, 10.1016/j.atherosclerosis.2016.07.925 Al-Numair, 2010, Type II diabetic rats and the hypolipidemic effect of camel milk, Journal of Food Agriculture and Environment, 8, 77 Al-Omran, 2012, Atherosclerotic disease and risk factor modification in Saudi Arabia: A call to action, Vascular Health and Risk Management, 8, 349, 10.2147/VHRM.S32783 Baguley, 2012 Baigent, 2005, Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins, Lancet, 366, 1267, 10.1016/S0140-6736(05)67394-1 Basulaiman, 2014, Hypercholesterolemia and its associated risk factors-Kingdom of Saudi Arabia, 2013, Annals of Epidemiology, 24, 801, 10.1016/j.annepidem.2014.08.001 Byington, 1995, Reduction in cardiovascular events during pravastatin therapy. Pooled analysis of clinical events of the Pravastatin Atherosclerosis Intervention Program, Circulation, 92, 2419, 10.1161/01.CIR.92.9.2419 Camerino, 2017, Risk of myopathy in patients in therapy with statins: Identification of biological markers in a pilot study, Frontiers in Pharmacology, 8, 10.3389/fphar.2017.00500 Caparros-Martin, 2017, Statin therapy causes gut dysbiosis in mice through a PXR-dependent mechanism, Microbiome, 5, 10.1186/s40168-017-0312-4 Clifton, 2004, Cholesterol-lowering effects of plant sterol esters differ in milk, yoghurt, bread and cereal, European Journal of Clinical Nutrition, 58, 503, 10.1038/sj.ejcn.1601837 Cohen, 1992, A power primer, Psychological Bulletin, 112, 155, 10.1037/0033-2909.112.1.155 Ejtahed, 2015, Effect of camel milk on blood sugar and lipid profile of patients with type 2 diabetes: A pilot clinical trial, International Journal of Endocrinology and Metabolism, 13 El Agamy, 1992, Antibacterial and antiviral activity of camel milk protective proteins, Journal of Dairy Research, 59, 169, 10.1017/S0022029900030417 Farah, 1992, Vitamin content of camel milk, International Journal for Vitamin and Nutrition Research, 62, 30 Ford, 2016, High-sensitivity cardiac troponin, statin therapy, and risk of coronary heart disease, Journal of the American College of Cardiology, 68, 2719, 10.1016/j.jacc.2016.10.020 Goodman, 1988, Evidence and scientific research, American Journal of Public Health, 78, 1568, 10.2105/AJPH.78.12.1568 Grundy, 2004, Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines, Circulation, 110, 227, 10.1161/01.CIR.0000133317.49796.0E Hailu, 2016, Functional and technological properties of camel milk proteins: A review, Journal of Dairy Research, 83, 422, 10.1017/S0022029916000686 Heart Protection Study Collaborative Group, 2002, MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals, Lancet, 360, 7, 10.1016/S0140-6736(02)09327-3 Kones, 2015, Current treatment of dyslipidaemia: A new paradigm for statin drug use and the need for additional therapies, Drugs, 75, 1187, 10.1007/s40265-015-0428-4 Konuspayeva, 2008, Fatty acid and cholesterol composition of camel's (Camelus bactrianus, Camelus dromedarius and hybrids) milk in Kazakhstan, Dairy Science & Technology, 88, 327, 10.1051/dst:2008005 Korish, 2013, Camel milk ameliorates steatohepatitis, insulin resistance and lipid peroxidation in experimental non-alcoholic fatty liver disease, BMC Complementary and Alternative Medicine, 13, 10.1186/1472-6882-13-264 Kotb-El-Sayed, 2011, Effects of camel's milk as a vehicle for insulin on glycaemic control and lipid profile in type 1 diabetics, American Journal of Biochemistry and Biotechnology, 7, 179, 10.3844/ajbbsp.2011.179.189 Lakens, 2017, Equivalence tests: A practical primer for t-tests, correlations, and meta-analyses, Social Psychological and Personality Science, 1, 1 Laslett, 2012, The worldwide environment of cardiovascular disease: Prevalence, diagnosis, therapy, and policy issues: A report from the american college of cardiology, Journal of the American College of Cardiology, 60, S1, 10.1016/j.jacc.2012.11.002 Lella, 2013, A comparative study of efficacy of atorvastatin alone and its combination with fenofibrate on lipid profile in type 2 diabetes mellitus patients with hyperlipidemia, Journal of Advanced Pharmaceutical Technology and Research, 4, 166, 10.4103/2231-4040.116778 Liu, 2016, Efficacy of high intensity atorvastatin versus moderate intensity atorvastatin for acute coronary syndrome patients with diabetes mellitus, International Journal of Cardiology, 222, 22, 10.1016/j.ijcard.2016.07.140 Mansi, 2015, Statins and new-onset diabetes mellitus and diabetic complications: A retrospective cohort study of us healthy adults, Journal of General Internal Medicine, 30, 1599, 10.1007/s11606-015-3335-1 Naci, 2013, Comparative benefits of statins in the primary and secondary prevention of major coronary events and all-cause mortality: A network meta-analysis of placebo-controlled and active-comparator trials, European Journal of Preventive Cardiology, 20, 641, 10.1177/2047487313480435 Punekar, 2017, Lipid-lowering treatment modifications among patients with hyperlipidemia and a prior cardiovascular event: A us retrospective cohort study, Current Medical Research and Opinion, 33, 869, 10.1080/03007995.2017.1292898 Rahman, 1997, High prevalence of metabolic risk factors for cardiovascular diseases among Saudi population, aged 30-64 years, International Journal of Cardiology, 62, 227, 10.1016/S0167-5273(97)00268-4 Ray, 2010, Statins and all-cause mortality in high-risk primary prevention: A meta-analysis of 11 randomized controlled trials involving 65,229 participants, Archives of Internal Medicine, 170, 1024, 10.1001/archinternmed.2010.182 Royall, 1997, 195 Ruscica, 2014, Statin therapy and related risk of new-onset type 2 diabetes mellitus, European Journal of Internal Medicine, 25, 401, 10.1016/j.ejim.2014.03.003 Russo, 2014, The spectrum of statin hepatotoxicity: Experience of the drug-induced liver injury network, Hepatology, 60, 679, 10.1002/hep.27157 Salami, 2011, Biological activity of camel milk casein following enzymatic digestion, Journal of Dairy Research, 78, 471, 10.1017/S0022029911000628 Sawaya, 1984, Chemical composition and nutritional quality of camel milk, Journal of Food Science, 49, 744, 10.1111/j.1365-2621.1984.tb13200.x Shareha, 2016, Effect of raw camel milk on type 2 diabetic patients, The Libyan Journal of Agriculture, 21, 74 Smith, 2012, Our time: A call to save preventable death from cardiovascular disease (heart disease and stroke), Circulation, 126, 2769, 10.1161/CIR.0b013e318267e99f Stroes, 2015, Statin-associated muscle symptoms: Impact on statin therapy—european atherosclerosis society consensus panel statement on assessment, aetiology and management, European Heart Journal, 36, 1012, 10.1093/eurheartj/ehv043 Vaughan, 2004, Update on statins: 2003, Circulation, 110, 886, 10.1161/01.CIR.0000139312.10076.BA WHO, 1986 Yahya, 2017, Antihypertensive effect of fermented skim camel (Camelus dromedarius) milk on spontaneously hypertensive rats, Nutricion Hospitalaria, 34, 416, 10.20960/nh.1163 Yan, 2013, Efficacy and safety evaluation of intensive statin therapy in older patients with coronary heart disease: A systematic review and meta-analysis, European Journal of Clinical Pharmacology, 69, 2001, 10.1007/s00228-013-1570-0 Zhang, 2013, Discontinuation of statins in routine care settings: A cohort study, Annals of Internal Medicine, 158, 526, 10.7326/0003-4819-158-7-201304020-00004 Zhao, 2017, An integrated method of therapeutic lifestyle change for older adults with dyslipidaemia, Public Health, 148, 30, 10.1016/j.puhe.2017.02.013